The results of this study suggest that the novel mechanism of action of ONL1204 as a small peptide acting to inhibit the interaction of the Fas receptor with Fas ligand may offer new opportunities to slow the progression of GA associated with AMD. This evidence concerns the gene FASLG and age-related macular degeneration.